Today: 10 June 2026
Robinhood stock slips as order-flow settlement notice lands; crypto-linked names softer

Robinhood stock slips as order-flow settlement notice lands; crypto-linked names softer

New York, Jan 6, 2026, 11:29 EST — Regular session

  • Robinhood shares fall even as the broader market edges higher
  • A proposed $2 million settlement in an order-flow case was posted Monday
  • Traders are watching Friday’s U.S. jobs report and Robinhood’s Feb. 10 results

Robinhood Markets, Inc. shares were down 1.7% at $121.20 in late morning trading on Tuesday, lagging a modest rise in U.S. equities as crypto-linked names cooled with bitcoin off its session highs. Coinbase fell 0.9%, while Charles Schwab rose 0.7%.

The moves matter because Robinhood’s revenue is tightly tied to customer trading activity, which often tracks swings in risk appetite — from crypto to options. With big macro data due later this week, some investors were trimming exposure to high-beta brokerage names after a strong start to the year.

A legal notice posted on Monday said a proposed $2 million settlement had been reached in In re Robinhood Order Flow Litigation, covering certain U.S. customers who traded during 2016–2018 and met specific execution-price criteria. A court hearing to consider final approval is set for May 5, the notice said.

The suit centers on “payment for order flow,” a common brokerage practice where trading firms pay brokers to route customer orders. The notice referenced executions compared with the “National Best Bid and Offer,” the top displayed buy and sell prices across U.S. exchanges at a given moment.

More broadly, Wall Street was modestly higher, led by healthcare and technology, as investors looked ahead to Friday’s U.S. nonfarm payrolls report for clues on the Federal Reserve’s rate path.

Robinhood’s next major company catalyst is its fourth-quarter and full-year 2025 report on Feb. 10, after the close, with a video call featuring CEO Vlad Tenev and incoming CFO Shiv Verma, the company has said.

But risks remain. Legal and regulatory scrutiny of order routing and trading practices can flare up without warning, and softer crypto prices can cool retail activity — a key driver for Robinhood’s transaction-heavy model.

For now, traders are watching whether the stock holds near the $120 level and how risk assets react to Friday’s jobs data (Jan. 9), with Robinhood’s Feb. 10 earnings report the next company-specific test.

Stock Market Today

  • Gold, Silver, Bitcoin Drop as Fed Rate Hike Odds Climb
    June 10, 2026, 9:07 AM EDT. Gold, silver, and bitcoin prices fell sharply on Wednesday as investors recalibrated expectations for U.S. Federal Reserve interest rates. Gold dropped about 2.4% and silver slid up to 2.8% amid fears of higher inflation and a hawkish Fed stance. Traders now see a near-certain chance the Fed will hold rates steady this week but price in a roughly 40% probability of a rate hike by October. Recent stronger U.S. jobs data fueled these bets. Stocks and ETFs linked to precious metals also declined, while bitcoin traded down 1.3%. Analysts note that rising real yields (adjusted for inflation) are creating headwinds for non-yielding assets like gold and silver, despite geopolitical tensions in the Middle East pushing oil prices higher. The European Central Bank is also expected to raise rates, reinforcing the tightening global monetary outlook.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings
Previous Story

Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings

Uber stock hit by Melius “Sell” call as robotaxi threat sharpens; Wolfe sets $110 target
Next Story

Uber stock hit by Melius “Sell” call as robotaxi threat sharpens; Wolfe sets $110 target

Go toTop